Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Mechanism of relapse in pediatric acute lymphoblastic leukemia.

Henderson MJ, Choi S, Beesley AH, Sutton R, Venn NC, Marshall GM, Kees UR, Haber M, Norris MD.

Cell Cycle. 2008 May 15;7(10):1315-20. Epub 2008 Feb 29.

PMID:
18418081
2.

BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.

Mullighan CG, Miller CB, Radtke I, Phillips LA, Dalton J, Ma J, White D, Hughes TP, Le Beau MM, Pui CH, Relling MV, Shurtleff SA, Downing JR.

Nature. 2008 May 1;453(7191):110-4. doi: 10.1038/nature06866. Epub 2008 Apr 13.

PMID:
18408710
3.

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study.

Borowitz MJ, Devidas M, Hunger SP, Bowman WP, Carroll AJ, Carroll WL, Linda S, Martin PL, Pullen DJ, Viswanatha D, Willman CL, Winick N, Camitta BM; Children's Oncology Group.

Blood. 2008 Jun 15;111(12):5477-85. doi: 10.1182/blood-2008-01-132837. Epub 2008 Apr 3.

4.
5.

The transcriptional regulation of B cell lineage commitment.

Nutt SL, Kee BL.

Immunity. 2007 Jun;26(6):715-25. Review. Erratum in: Immunity. 2007 Aug;27(2):361.

6.

High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression.

Kuiper RP, Schoenmakers EF, van Reijmersdal SV, Hehir-Kwa JY, van Kessel AG, van Leeuwen FN, Hoogerbrugge PM.

Leukemia. 2007 Jun;21(6):1258-66. Epub 2007 Apr 19.

PMID:
17443227
7.

Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone.

Choi S, Henderson MJ, Kwan E, Beesley AH, Sutton R, Bahar AY, Giles J, Venn NC, Pozza LD, Baker DL, Marshall GM, Kees UR, Haber M, Norris MD.

Blood. 2007 Jul 15;110(2):632-9. Epub 2007 Mar 19.

8.

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia.

Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, Dalton JD, Girtman K, Mathew S, Ma J, Pounds SB, Su X, Pui CH, Relling MV, Evans WE, Shurtleff SA, Downing JR.

Nature. 2007 Apr 12;446(7137):758-64.

PMID:
17344859
9.

Glucocorticoid resistance in two key models of acute lymphoblastic leukemia occurs at the level of the glucocorticoid receptor.

Schmidt S, Irving JA, Minto L, Matheson E, Nicholson L, Ploner A, Parson W, Kofler A, Amort M, Erdel M, Hall A, Kofler R.

FASEB J. 2006 Dec;20(14):2600-2. Epub 2006 Oct 31.

PMID:
17077285
10.

Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial.

Vora A, Mitchell CD, Lennard L, Eden TO, Kinsey SE, Lilleyman J, Richards SM; Medical Research Council; National Cancer Research Network Childhood Leukaemia Working Party.

Lancet. 2006 Oct 14;368(9544):1339-48.

PMID:
17046466
11.

Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children's Oncology Group study.

Bhojwani D, Kang H, Moskowitz NP, Min DJ, Lee H, Potter JW, Davidson G, Willman CL, Borowitz MJ, Belitskaya-Levy I, Hunger SP, Raetz EA, Carroll WL.

Blood. 2006 Jul 15;108(2):711-7.

12.

Treatment of acute lymphoblastic leukemia.

Pui CH, Evans WE.

N Engl J Med. 2006 Jan 12;354(2):166-78. Review. No abstract available.

PMID:
16407512
13.

Childhood acute lymphoblastic leukaemia and relapse.

Gaynon PS.

Br J Haematol. 2005 Dec;131(5):579-87. Review.

PMID:
16351633
14.

The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: implications for mechanisms of therapy failure.

Beesley AH, Cummings AJ, Freitas JR, Hoffmann K, Firth MJ, Ford J, de Klerk NH, Kees UR.

Br J Haematol. 2005 Nov;131(4):447-56.

PMID:
16281934
15.

Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia.

Lugthart S, Cheok MH, den Boer ML, Yang W, Holleman A, Cheng C, Pui CH, Relling MV, Janka-Schaub GE, Pieters R, Evans WE.

Cancer Cell. 2005 Apr;7(4):375-86.

16.

Loss of heterozygosity in childhood acute lymphoblastic leukemia detected by genome-wide microarray single nucleotide polymorphism analysis.

Irving JA, Bloodworth L, Bown NP, Case MC, Hogarth LA, Hall AG.

Cancer Res. 2005 Apr 15;65(8):3053-8.

17.

Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia.

Rivera GK, Zhou Y, Hancock ML, Gajjar A, Rubnitz J, Ribeiro RC, Sandlund JT, Hudson M, Relling M, Evans WE, Pui CH.

Cancer. 2005 Jan 15;103(2):368-76.

18.

Circular binary segmentation for the analysis of array-based DNA copy number data.

Olshen AB, Venkatraman ES, Lucito R, Wigler M.

Biostatistics. 2004 Oct;5(4):557-72.

PMID:
15475419
19.
20.

Dominant effects of an Msh6 missense mutation on DNA repair and cancer susceptibility.

Yang G, Scherer SJ, Shell SS, Yang K, Kim M, Lipkin M, Kucherlapati R, Kolodner RD, Edelmann W.

Cancer Cell. 2004 Aug;6(2):139-50.

Supplemental Content

Support Center